Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.60−0.05 (-0.02%)
Close on Nov 13, 2026Market cap $28.56BP/E 25.9Yield –
Quest Diagnostics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Quest Diagnostics's EV/EBITDA was 15.6× on Nov 11, 2026, against 12.8× a year earlier. Over the last 5 years it ranged from 6.8× to 15.6×, with a median of 12.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.6× | +3.6 |
| 2025 | Dec 31, 2025 | 12.0× | −1.1 |
| 2024 | Dec 31, 2024 | 13.0× | +0.4 |
| 2023 | Dec 29, 2023 | 12.6× | +2.8 |
| 2022 | Dec 30, 2022 | 9.8× | +1.4 |
| 2021 | Dec 31, 2021 | 8.4× | −1.8 |
| 2020 | Dec 31, 2020 | 10.2× | −2.7 |
| 2019 | Dec 31, 2019 | 12.9× | +2.5 |
| 2018 | Dec 31, 2018 | 10.4× | −1.6 |
| 2017 | Dec 29, 2017 | 12.0× | +1.0 |
| 2016 | Dec 30, 2016 | 11.1× | +3.0 |
| 2015 | Dec 31, 2015 | 8.1× | −2.2 |
| 2014 | Dec 31, 2014 | 10.3× | +3.7 |
| 2013 | Dec 31, 2013 | 6.6× | −3.4 |
| 2012 | Dec 31, 2012 | 10.0× | +1.5 |
| 2011 | Dec 30, 2011 | 8.5× | +0.5 |
| 2010 | Dec 31, 2010 | 7.9× | +0.9 |
| 2009 | Dec 31, 2009 | 7.1× | – |
See a number that looks wrong?